With this ambitious project announced in 2017, Arkema is delivering on its strong commitment to Specialty Materials and the bio-based polyamide 11 chain. When complete, this will represent the biggest integrated bio-factory in the world dedicated to high performance polymers. It represents a 50% increase in global polyamide 11 capacity for Arkema.
The total investment in the region, which also includes downstream polymer capacities in China, is approximately €450 million. To finance this new plant in Singapore, Arkema successfully placed its first ever green bond in October 2020, for a total amount of €300 million.
After a first phase of in-depth studies and administrative procedures, our technical teams have started work on the infrastructure and construction of this large-scale industrial complex on the Jurong site (Singapore).
After overcoming the difficulties linked to the Covid-19, this project is fully on track and the Group confirms its ambition to start up production in the first half of 2022.
This investment supports strong growth in demand for advanced bio-circular materials. Rilsan® polyamide 11 is recognized worldwide for its superior properties and performance in very demanding applications, significantly contributing to the development of sustainable solutions in fast-growing sectors, such as new energy vehicles, 3D printing, as well as consumer goods, electronics, sports and lifestyle markets.
We are excited to maintain the momentum and speed of construction. After facing early challenges due to the global pandemic, we are operating at full strength and are now entering the peak construction phase with an estimated 2,000 workers on site during the summer months. The enthusiasm of our team in Singapore is stronger than ever, supported by the vigorous demand from our customers for sustainable and cutting edge solutions.”